Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    • News

  • March 2025 quarter CPI above expectations – but RBA cut still likely
    March 2025 quarter CPI above expectations – but RBA cut still likely
    • News

  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    • News

  • PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    • News

  • Impact Minerals Accelerates HPA Market Entry with Strategic HiPurA® Acquisition
    Impact Minerals Accelerates HPA Market Entry with Strategic HiPurA® Acquisition
    • News

  • Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion
    Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion
    • News

  • Condor Confirms 3 Billion Barrel Oil Potential in Tumbes Basin
    Condor Confirms 3 Billion Barrel Oil Potential in Tumbes Basin
    • News

  • Atomo Scales Up HIV Self-Testing Through National Vending Machine Rollout
    Atomo Scales Up HIV Self-Testing Through National Vending Machine Rollout
    • News

  • Spenda Secures $3M Term Loan to Accelerate Growth
    Spenda Secures $3M Term Loan to Accelerate Growth
    • News

Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion

  • In News
  • April 17, 2025
  • Gracen Moore
Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion

Equity Story Group Taps Booming Advisory Sector

Equity Story Group Ltd (ASX:EQS) has taken a major step into full-service wealth management, signing a binding agreement to acquire long-standing financial advisory firm Baker Young Limited. The strategic acquisition aims to expand Equity Story’s footprint into retail stockbroking and corporate advisory—two segments showing significant growth amid increasing demand for tailored financial advice in Australia.

“This opportunity expands our wealth advisory platform, strengthens our corporate advisory reach, and delivers national scale,” said Shane White, CEO of Equity Story Group.

The deal brings more than $700 million in funds under management into the Equity Story fold, including $180 million under Managed Discretionary Accounts. With audited FY24 revenue of $4.5 million and a strong client base of over 6,000 accounts, Baker Young offers immediate scale and diversification to Equity Story’s business model.

Targeting Scale With Established Trust

Based in Adelaide, Baker Young has a 40-year legacy of providing advice across equities execution, portfolio management, and capital markets. The business operates a robust Individually Managed Account (IMA) platform, and its team has earned a reputation for consistent performance and client trust.

“We’ve spent four decades building Baker Young on a foundation of trust, personalised service, and consistent performance,” said founders Alan Young and David Baker. “Joining Equity Story allows us to continue that tradition while expanding our reach, resources, and digital capabilities.”

Importantly, both founders will remain with the business post-acquisition, helping ensure continuity as Baker Young becomes a division of Equity Story and the foundation for a national expansion strategy.

$4.2 Million Deal With Earnings Upside

Under the agreement, Equity Story will acquire Baker Young’s business and specified assets for $4.2 million. That includes a $3 million upfront payment, with a $1.2 million performance-based earn-out over the next 10 months. The transaction will be fully funded through debt.

Equity Story will also issue 10 million escrowed options to the seller’s nominees, pending shareholder approval. Half of the options will be escrowed for six months, the remainder for 12 months.

“The acquisition is expected to be earnings-accretive,” said White. “It aligns with our commitment to delivering accessible, high-quality wealth services across Australia.”

Synergies Across Research, Advice, And Tech

Baker Young’s research-driven advisory approach complements Equity Story’s proprietary CTM (Chart, Timing, Momentum) trading system. The combination offers clients a unique blend of technical and fundamental insights, reinforcing the company’s mission to improve investment outcomes. 

Executive Chairman Brendan Gow sees the move as a textbook fit.

“This acquisition exemplifies our thesis of consolidating high-quality advisory practices under a forward-thinking brand,” Gow said. “As the advisory sector faces generational change and regulatory pressures, we see a clear opportunity to partner with legacy firms ready for scalable, tech-enabled growth.”

Conditions Still Pending

While the agreement is binding, the deal remains subject to several conditions—including completion of due diligence, execution of formal sale documentation, and regulatory approvals. A formal asset sale and purchase agreement must be signed by 31 May 2025.

Thomson Geer is advising Equity Story on the transaction.

What’s Next For Equity Story?

The acquisition represents a significant milestone in Equity Story’s strategy to transform into a full-spectrum financial services provider. With Baker Young’s infrastructure, Equity Story adds both scale and credibility to its Wealth Management division, unlocking further opportunities to attract advisors and grow its client base.

“Executing a strategic acquisition like Baker Young so early in my tenure as CEO signals a new phase of growth, ambition, and capability,” White said. “Exciting times ahead for the Group.”

  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path - May 6, 2025
  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program - May 1, 2025
  • March 2025 quarter CPI above expectations – but RBA cut still likely - April 30, 2025
  •  
  •  
  •  
  •  
  • ASX:EQS
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path - May 6, 2025
  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program - May 1, 2025
  • March 2025 quarter CPI above expectations – but RBA cut still likely - April 30, 2025

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Gracen Moore
Latest posts by Gracen Moore (see all)
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path - May 6, 2025
  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program - May 1, 2025
  • March 2025 quarter CPI above expectations – but RBA cut still likely - April 30, 2025
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.